News

Apogee Therapeutics Announces Conference Participation Details

Apogee Therapeutics Announces Conference Participation Details

Apogee Therapeutics Engages with Investors at Upcoming Conferences

Apogee Therapeutics, Inc. (NASDAQ: APGE), based in San Francisco and Boston, has made significant strides in the biotechnology field. The company has announced its participation in several investor conferences that provide great opportunities to showcase its innovative research and development in immunology.

Schedule of Upcoming Investor Conferences

Apogee Therapeutics has outlined its conference schedule, featuring notable events where management will engage directly with investors:

Guggenheim's 2nd Annual Healthcare Innovation Conference

Scheduled for a Tuesday, the discussions will kick off with a fireside chat at 1:30 p.m. ET. Investors can expect insights into Apogee's advancements and future strategies.

Stifel 2025 Healthcare Conference

This event will take place on Wednesday, featuring a fireside chat at 11:20 a.m. ET, where Apogee will further elaborate on its growth and product pipeline.

TD Cowen Immunology and Inflammation Virtual Summit

On Thursday, Apogee will participate in a virtual summit focusing on immunology, presenting a fireside chat at 12:30 p.m. ET, delving into their innovative approaches.

Jefferies London Healthcare Conference

Next Wednesday, the company will engage with international investors at the Jefferies Conference, with a fireside chat scheduled for 3:00 p.m. GMT / 10:00 a.m. ET.

Citi 2025 Global Healthcare Conference

Wrapping up the conference season, Apogee will present at this event on Wednesday, where their fireside chat will commence at 9:45 a.m. ET.

Webcast Availability

For those unable to attend, Apogee will provide live and archived webcasts of these events on their official website within the Investors section. This initiative opens the door for a wider audience to stay informed about Apogee's developments.

About Apogee Therapeutics

As a clinical-stage biotechnology leader, Apogee Therapeutics is committed to pioneering innovative biologics aimed at addressing major unmet medical needs in immunology. Their portfolio focuses on conditions such as Atopic Dermatitis (AD), asthma, Eosinophilic Esophagitis (EoE), and Chronic Obstructive Pulmonary Disease (COPD). The firm’s leading program, APG777, aims to revolutionize treatment for AD, emphasizing advancements in antibody engineering to improve therapeutic efficacy.

Apogee's strategic direction is built on a foundation of robust scientific expertise and groundbreaking research, which they believe will yield significant benefits for patients who currently receive inadequate care. Their mission reflects a deep commitment to improving health outcomes in chronic conditions.

Contact Information

Investor Contact:
Noel Kurdi
VP, Investor Relations
Apogee Therapeutics, Inc.
noel.kurdi@apogeetherapeutics.com

Media Contact:
Dan Budwick
1AB
dan@1abmedia.com

Frequently Asked Questions

What is the focus of Apogee Therapeutics?

Apogee Therapeutics focuses on advancing biologics targeting immunology, particularly in diseases like Atopic Dermatitis and asthma.

When is the next investor conference for Apogee?

Apogee's next conference is the Guggenheim 2nd Annual Healthcare Innovation Conference on Tuesday, with discussions starting at 1:30 p.m. ET.

How can investors access the conference webcasts?

Investors can access live and archived webcasts through the Investors section on Apogee's official website.

Who should be contacted for investor relations?

Noel Kurdi, the VP of Investor Relations at Apogee, is the key contact for investor inquiries.

What is APG777?

APG777 is Apogee Therapeutics' leading antibody program aimed at treating Atopic Dermatitis, showcasing their innovative research in the immunology sector.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

WareSpace Expands Reach With $36.5M Acquisitions

Updated Category News Views 3

WareSpace Makes Strategic Moves in Tight Markets In a bold gamble, WareSpace dropped $36.5 million to snag fresh industrial real estate in Miami Gardens, Florida, and South San Francisco, California. These aren't random picks, mind you. They're strategic grabs in markets where finding space ain't easier than winning the lottery. With more than 210 flexible units for small...

Continue Reading
Guaranteed Roof Expands with EM Exteriors through LB Capital

Updated Category News Views 5

A Bold Move to Elevate Roofing Standards In a move that seems to jolt the roofing industry awake, Guaranteed Roof is taking the wraps off its new strategic partnership with LB Capital and EM Exteriors. Think of it as a power trio aiming to redefine what roofing solutions should mean in the Southeast. It’s the kind of news that makes you sit up and ask, why now and why...

Continue Reading
EnGenius Names Experienced VP to Boost Sales Growth

Updated Category News Views 3

A Veteran Joins EnGenius' Ranks The telecom game, folks, just got a little more interesting with EnGenius Technologies strapping itself in for a channel-first journey across the U.S. and Canada. They've placed a seasoned player, Rachel Saunders, into the cockpit as Vice President of Sales, North America. Her resume reads like a telecom scout's dream: 17 years in electric...

Continue Reading
Linkind's Light Stick Revolutionizes Retail Lighting Experience

Updated Category News Views 5

Transforming Lighting in Retail Spaces Folks, let's talk lighting. Not the humdrum switch-you-on kind, but something much snazzier, more customized, and downright interactive. I'm talking about Linkind's latest brainchild—the Smart Light Stick. Launched amidst the neon rush of tm:rw in New York City, this gizmo isn't just another bulb in the home improvement aisle. It's...

Continue Reading
Beetles Gel Polish Unveils Vibrant Fall Nail Carnival

Updated Category News Views 6

Beetles Gel Polish Launches Fall Nail Carnival Here comes a new twist on fall fashion, and no, it ain’t your grandma's knitted sweater. We're talking nail polish—a vibrant, flashy ordeal brought to you by Beetles Gel Polish with their Fall Nail Carnival. They're rolling out this spectacle not just for your visions of grandeur nail ideas, but for those seeking deals...

Continue Reading
Omneky Integrates AI Growth Agent With Slack for Ads

Updated Category News Views 5

Omneky's New Move: AI Growth Agent Meets Slack Picture this: You've got a marketing team hustling in the digital age, and now they've got a new ally. Omneky, the big-wig in autonomous AI growth, has snuck its AI Growth Agent right into Slack. This isn't just a party trick during Dreamforce week in San Francisco. This is Omneky throwing another cog into the advertising...

Continue Reading
Chad Tucker's Sequel Explores Deep Spiritual Themes

Updated Category News Views 6

An Honest Take: Faith, Growth, and Surrender A player in the world of spiritual growth literature has stepped up again, and it ain't holding back. Chad Tucker, a name perhaps familiar to folks following transformation tales soaked with faith, has released a beefy sequel to his first hit: The Lord in Us: If You Can Love an Enemy, You Can Love Anyone. Well, now he's back...

Continue Reading
Metriport Eyes Major Step in Health Data Integration

Updated Category News Views 6

Metriport's Push into the TEFCA Framework Son of a gun, Metriport's making noise in the health data world! They just got the nod as a Candidate QHIN under the Trusted Exchange Framework and Common Agreement, or TEFCA if you're into acronyms. This isn't just some digital high-five; it's a significant stride forward for healthcare data exchange. Now they're smack in the...

Continue Reading
Foodcare Proves Effective in Reducing Blood Sugar Levels

Updated Category News Views 6

A New Chapter for Diabetes Care: Foodcare Folks, we've got ourselves a game-changer in the world of diabetes care. Listen closely: Foodsmart's latest study, hot off the press from the American Heart Association's Circulation, essentially hands over the blueprint for tackling type 2 diabetes in an innovative fashion. Now, I'm not the type to get all mushy over scientific...

Continue Reading
Donatos Targets Texas: Pushing Franchise Growth Limits

Updated Category News Views 6

Donatos Pizza: Ambitious Expansion in the Lone Star State When you think about pizza chains expanding, Donatos Pizza might not be the first name to come to mind, but they're cooking up something big in Texas. Folks in Dallas and Houston better be ready because Donatos is rolling out the red carpet for its edge-to-edge, topping-loaded pies all over Texas. Strategic Growth:...

Continue Reading

Top 5 Most Recently Viewed Articles

HSBC Sells German Private Banking Business to BNP Paribas

Updated Category News Views 161

HSBC Continental Europe Sells Private Banking Unit HSBC Continental Europe has made waves with its decision to sell its private banking operations in Germany to BNP Paribas. This noteworthy move indicates a strategic change for HSBC as it aims to refocus its efforts and streamline its business model in the region. Transaction Details The sale hinges on obtaining necessary...

Continue Reading
Inbank Finance Addresses Regulatory Precept from Estonian FSA

Updated Category News Views 205

Inbank Finance Responds to Regulatory Oversight The recent actions taken by the Estonian Financial Supervision and Resolution Authority (FSA) highlight the ongoing commitment to maintaining integrity within the financial industry. On a notable date, a precept was issued specifically to AS Inbank Finance, a subsidiary known for its innovative approach in the realm of...

Continue Reading
Discover the Unique Offerings of J. Mattingly 1845 Distillery

Updated Category News Views 252

Exciting Bourbon Deals Await at J. Mattingly 1845 Distillery Kentucky has long been famed for its bourbon, and J. Mattingly 1845 Distillery is right at the heart of this beloved tradition. This distillery is celebrating a fantastic year filled with accolades for its exceptional double-staved™ bourbon. To mark this occasion, they are embracing the holiday spirit with a...

Continue Reading
Fiber Deployment Costs: Insights from the Fiber Broadband Association

Updated Category News Views 726

Fiber Deployment Costs: Insights from the Fiber Broadband Association The Fiber Broadband Association has recently shared critical findings regarding the costs associated with fiber deployment. This annual report, initiated by Cartesian, seeks to unravel the complexities surrounding fiber broadband deployment, revealing significant insights for both industry stakeholders...

Continue Reading
Intellia Therapeutics to Showcase Significant Investor Insights

Updated Category News Views 58

Upcoming Investor Events from Intellia Therapeutics Intellia Therapeutics, Inc. (NASDAQ:NTLA), a pioneering company in the field of gene editing, has announced its participation in two significant investor events coming up this November. These events will provide vital insights into the company’s advancements in gene therapies and operational performance. Investors can...

Continue Reading